Sanofi India · NSE: SANOFI · BSE: 500674
Q1 FY20 results · Apr–Jun 2019
Sanofi India reported revenue from operations of ₹747.90 crore (up 9.4% from Q1 FY19) and net profit of ₹97.40 crore (down 2.2% from Q1 FY19) for Q1 FY20 (Apr–Jun 2019), on a standalone basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 747.90 | 683.60 | +9.4% | 717.30 | +4.3% |
| Other income | 23.40 | 20.80 | +12.5% | 23.00 | +1.7% |
| Total income | 771.30 | 704.40 | +9.5% | 740.30 | +4.2% |
| Profit before tax | 155.20 | 159.90 | −2.9% | 150.70 | +3.0% |
| Net profit for the period | 97.40 | 99.60 | −2.2% | 92.90 | +4.8% |
| EPS, basic (₹) | 42.29 | 43.30 | −2.3% | 40.34 | +4.8% |
| Net margin (%) | 13.0 | 14.6 | 13.0 |
Standalone
- Filed with BSE
- 30 Jul 2019, 11:46 IST
- Board meeting
- 29 Jul 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE